(Q52961647)

9 May 2018

title

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. (English)

1 reference

9 May 2018

author

Christian Becker

1

1 reference

9 May 2018

author name string

Pohla H

2

1 reference

9 May 2018

Frankenberger B

3

1 reference

9 May 2018

Schüler T

4

1 reference

9 May 2018

Assenmacher M

5

1 reference

9 May 2018

Schendel DJ

6

1 reference

9 May 2018

Blankenstein T

7

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 October 2001

1 reference

9 May 2018

published in

Nature Medicine

1 reference

9 May 2018

volume

7

1 reference

9 May 2018

issue

10

1 reference

9 May 2018

page(s)

1159-1162

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1038/nm1001-1159

exact match

0 references

cites work

Principles for adoptive T cell therapy of human viral diseases

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Prospects for adoptive T cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

The role of CD4+ T cell responses in antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Enrichment and detection of live antigen-specific CD4(+) and CD8(+) T cells based on cytokine secretion

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte respons

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Allogeneic vaccination for renal cell carcinoma: development and monitoring

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1159

7 January 2021

Identifiers

DOI

10.1038/NM1001-1159

1 reference

9 May 2018

1 reference

9 May 2018